Share This Page
Drug Price Trends for NDC 00013-2651
✉ Email this page to a colleague
Average Pharmacy Cost for 00013-2651
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| GENOTROPIN MINIQUICK 0.6 MG | 00013-2651-02 | 88.22163 | EACH | 2024-12-18 |
| GENOTROPIN MINIQUICK 0.6 MG | 00013-2651-02 | 88.12929 | EACH | 2024-11-20 |
| GENOTROPIN MINIQUICK 0.6 MG | 00013-2651-02 | 88.12929 | EACH | 2024-10-23 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00013-2651
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
00013-2651 Market Analysis and Financial Projection
Market Analysis and Price Projections for the Drug NDC: 00013-2651
Introduction to NDC 00013-2651
The National Drug Code (NDC) 00013-2651 is a unique identifier assigned by the FDA to a specific pharmaceutical product. To analyze the market and project prices for this drug, it is essential to understand the broader pharmaceutical market, the specific drug's characteristics, and the factors influencing its pricing.
Understanding the Pharmaceutical Market
Global Pharmaceutical Market Trends
The global pharmaceutical market is expected to grow significantly, driven by factors such as increasing healthcare expenditure, rising prevalence of chronic diseases, and advancements in drug development technologies. For instance, the US pharmaceutical market alone is projected to grow from $846.72 billion in 2022 to $1.28 trillion by 2030, with a CAGR of 5.36%[2].
Biopharma and Biotech Sector Growth
The biopharma and biotech sectors are particularly vibrant, with the biopharma market estimated to be over $400 billion in 2024 and projected to grow at a CAGR of 7.56% until 2029. The biotech market, valued at nearly $500 billion in 2020, is expected to grow at a CAGR of 9.4% until 2027[3].
Factors Influencing Drug Pricing
Historical Pricing Data
Historical pricing data is crucial for understanding price trends and potential future adjustments. For NDC 00013-2651, analyzing past price changes can help predict future price movements[2].
Regulatory Changes
Regulatory changes, such as updates to the Medicaid Drug Rebate Program or new FDA guidelines, can significantly impact drug pricing. These changes can affect the Average Manufacturer Price (AMP) and the Unit Rebate Amount (URA), which are key in calculating the ceiling price for covered outpatient drugs[2].
Market Demand and Competition
The demand for the drug and the level of competition in the market are critical factors. High demand and limited competition can drive prices up, while increased competition, especially from generics or biosimilars, can lead to price stability or decreases[2].
Technological Advancements
Technological advancements, such as the adoption of AI and machine learning, can reduce development and manufacturing costs, potentially leading to lower prices. These advancements are also driving innovation in drug development, particularly in areas like precision medicine and personalized therapies[3][5].
Pricing Mechanisms
Average Manufacturer Price (AMP) and Unit Rebate Amount (URA)
For drugs covered under the Medicaid Drug Rebate Program, the 340B ceiling price is calculated by subtracting the URA from the AMP for the smallest unit of measure. This price is then adjusted by the package size and case pack size to determine the final ceiling price[2].
Example Calculation
If NDC 00013-2651 corresponds to a drug with the following parameters:
- AMP: $100 per unit
- URA: $20 per unit
- Package Size: 10 units
- Case Pack Size: 5 packages
The 340B ceiling price would be calculated as: [ \text{340B Ceiling Price} = (100 - 20) \times 10 \times 5 = \$4000 ]
This calculation provides a baseline for the ceiling price, but actual market prices can vary based on various factors including market demand, competition, and regulatory changes[2].
Market Segmentation and Distribution
Distribution Channels
The distribution channels for pharmaceuticals, such as drug stores, retail pharmacies, and online providers, play a significant role in pricing. For instance, the online providers segment is anticipated to be the fastest-growing segment during the forecast period, which could influence pricing strategies[1].
Regional Market Analysis
The global market for pharmaceuticals is analyzed across regions such as North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market in terms of revenue in 2022, but Asia-Pacific is expected to be the fastest-growing region due to rising healthcare expenditure and developing healthcare infrastructure[1].
Competitive Analysis
Key Players and Market Positioning
Major pharmaceutical companies, such as Eli Lilly and Company, Merck & Co., Inc., and Novo Nordisk A/S, are key players in the market. Their market positioning, marketing strategies, and partnerships with healthcare providers significantly influence the pricing and adoption of drugs like those identified by NDC 00013-2651[1].
Porter's Five Forces Analysis
Porter's five forces analysis highlights the potency of buyers and suppliers, enabling stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network. This analysis is crucial for understanding the competitive landscape and its impact on pricing[1].
Price Projections
Short-Term Projections
In the short term, prices for NDC 00013-2651 are likely to be influenced by current market demand, competition from similar drugs, and any recent regulatory changes. Historical pricing data and the drug's position within its therapeutic class will also play a role.
Long-Term Projections
Long-term price projections will be influenced by broader market trends, such as the growth of the biopharma and biotech sectors, advancements in drug development technologies, and changes in healthcare policies. The increasing focus on precision medicine and personalized therapies could also impact pricing as these approaches become more prevalent[3][5].
Key Takeaways
- Historical Pricing Data: Essential for understanding past price trends and predicting future adjustments.
- Regulatory Changes: Can significantly impact pricing through changes in AMP and URA.
- Market Demand and Competition: High demand and limited competition can drive prices up, while increased competition can lead to price stability or decreases.
- Technological Advancements: Can reduce costs and drive innovation, potentially leading to lower prices.
- Distribution Channels: Online providers are expected to be the fastest-growing segment, influencing pricing strategies.
- Regional Market Analysis: Asia-Pacific is expected to be the fastest-growing region due to rising healthcare expenditure and developing healthcare infrastructure.
FAQs
What are the key factors influencing drug pricing for NDC 00013-2651?
The key factors include historical pricing data, regulatory changes, market demand, competition, and technological advancements.
How do regulatory changes impact drug pricing?
Regulatory changes can affect the Average Manufacturer Price (AMP) and the Unit Rebate Amount (URA), which are used to calculate the ceiling price for covered outpatient drugs.
What role does market demand play in drug pricing?
High demand and limited competition can drive prices up, while increased competition, especially from generics or biosimilars, can lead to price stability or decreases.
How do technological advancements affect drug pricing?
Technological advancements, such as the adoption of AI and machine learning, can reduce development and manufacturing costs, potentially leading to lower prices.
Which distribution channel is expected to be the fastest-growing segment?
The online providers segment is anticipated to be the fastest-growing segment during the forecast period.
Sources
- Allied Market Research: "Incretin-Based Drugs Market Statistics, Forecast - 2032"
- DrugPatentWatch: "Market Analysis and Financial Projection Experimental"
- TFS CRO: "5 Predictions for the Biopharma and Biotech Industries in 2025"
- DrugPatentWatch: "Latest drug prices and trends for NDC 00054-0319"
- Deloitte Insights: "2025 life sciences outlook"
More… ↓
